Literature DB >> 19638962

Fibrolamellar hepatocellular carcinoma.

Shu Liu1, Kwok Wah Chan, Bingyuan Wang, Liang Qiao.   

Abstract

Fibrolamellar hepatocellular carcinoma (FHLCC) generally occurs in young individuals lacking a background of chronic liver disease and other risk factors for hepatocellular carcinoma. The clinical presentations of FLHCC are generally nonspecific, and the alpha-fetoprotein level is typically within the normal range in most cases. Imaging studies have a major role in clinical diagnosis, but pathology is the gold standard in confirming diagnosis. Pathological characteristics of FLHCC include the presence of tumor cells with a deeply eosinophilic cytoplasm and macronucleoli surrounded by abundant fibrous bands. The most effective treatment for FLHCC is aggressive surgical resection. This comprehensive literature review gives a full account of the clinical, pathological, and molecular features of FLHCC.

Entities:  

Mesh:

Year:  2009        PMID: 19638962     DOI: 10.1038/ajg.2009.440

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN: 0002-9270            Impact factor:   10.864


  33 in total

1.  Fibrolamellar hepatocellular carcinoma with cardiac spread causing severe inferior vena cava obstruction in a 9-year-old child.

Authors:  Jarrod D Knudson; Jason F Goldberg; Nancy A Ayres
Journal:  Pediatr Cardiol       Date:  2012-03-25       Impact factor: 1.655

2.  Fibrolamellar hepatocellular carcinoma with biliary tumor thrombus: an unreported association.

Authors:  Anna Maria De Gaetano; Erida Nure; Ugo Grossi; Francesco Frongillo; Rosellina Russo; Fabio Maria Vecchio; Maria Carmen Lirosi; Gabriele Sganga; Carla Felice; Lorenzo Bonomo; Salvatore Agnes
Journal:  Jpn J Radiol       Date:  2013-07-13       Impact factor: 2.374

3.  Frequency of TERT promoter mutations in primary tumors of the liver.

Authors:  Alexander Quaas; Theresa Oldopp; Lars Tharun; Catina Klingenfeld; Till Krech; Guido Sauter; Tobias J Grob
Journal:  Virchows Arch       Date:  2014-09-30       Impact factor: 4.064

Review 4.  [Overview: liver tumors].

Authors:  Ivo Graziadei
Journal:  Wien Med Wochenschr       Date:  2013-01-30

5.  Genomic analysis of fibrolamellar hepatocellular carcinoma.

Authors:  Lei Xu; Florette K Hazard; Anne-Flore Zmoos; Nadine Jahchan; Hassan Chaib; Phillip M Garfin; Arun Rangaswami; Michael P Snyder; Julien Sage
Journal:  Hum Mol Genet       Date:  2014-08-13       Impact factor: 6.150

6.  Prognostic indicators and treatment outcome in 94 cases of fibrolamellar hepatocellular carcinoma.

Authors:  Ahmed O Kaseb; Mohamed Shama; Ibrahim Halil Sahin; Ajay Nooka; Hesham M Hassabo; Jean-Nicolas Vauthey; Thomas Aloia; James L Abbruzzese; Ishwaria M Subbiah; Filip Janku; Steven Curley; Manal M Hassan
Journal:  Oncology       Date:  2013-09-19       Impact factor: 2.935

7.  Recommendations for liver transplantation for hepatocellular carcinoma: an international consensus conference report.

Authors:  Pierre-Alain Clavien; Mickael Lesurtel; Patrick M M Bossuyt; Gregory J Gores; Bernard Langer; Arnaud Perrier
Journal:  Lancet Oncol       Date:  2011-10-31       Impact factor: 41.316

8.  Molecular characteristics of fibrolamellar hepatocellular carcinoma.

Authors:  Attila Patonai; Boglárka Erdélyi-Belle; Anna Korompay; Aron Somorácz; Péter Törzsök; Ilona Kovalszky; Tamás Barbai; Erzsébet Rásó; Gábor Lotz; Zsuzsa Schaff; András Kiss
Journal:  Pathol Oncol Res       Date:  2012-08-08       Impact factor: 3.201

9.  Cell cycle biology of fibrolamellar hepatocellular carcinoma.

Authors:  Sadhna Dhingra; Wei Li; Dongfeng Tan; Maryam Zenali; Haizeng Zhang; Robert E Brown
Journal:  Int J Clin Exp Pathol       Date:  2010-11-02

10.  Frequent and distinct aberrations of DNA methylation patterns in fibrolamellar carcinoma of the liver.

Authors:  Wolfgang Tränkenschuh; Florian Puls; Matthias Christgen; Cord Albat; Albert Heim; Jeanette Poczkaj; Peer Fleming; Hans Kreipe; Ulrich Lehmann
Journal:  PLoS One       Date:  2010-10-29       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.